Status:
COMPLETED
BioXmark, Rectal Feasibility Trial
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To test the feasibility and accuracy of BioXmark fiducial markers for image guided radiotherapy (IGRT) based rectal tumor boosting in 20 patients referred for long course chemo-radiotherapy of the loc...
Detailed Description
This study is a prospective non-randomized open label trial. A total of 20 patients who will undergo neo-adjuvant chemo-radiotherapy for rectal cancer will be included in this study upon informed con...
Eligibility Criteria
Inclusion
- Patients with histological or cytological proven adenocarcinoma of the rectum, treated with long course external beam radiotherapy
- Age \> 18 years
- Have given written informed consent before patient registration
Exclusion
- Patients using anticoagulants: platelet aggregation inhibitors or coumarines
- Iodine allergy
Key Trial Info
Start Date :
January 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03265418
Start Date
January 2 2018
End Date
July 25 2019
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MAASTRO Clinic
Maastricht, Limburg, Netherlands, 6202 NA